Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
67 items
Eye Examination

Early Tight Blood Glucose Control Reduces Eye Surgeries in People with Type 1 Diabetes

People with type 1 diabetes who intensively control their blood glucose (blood sugar) early in their disease, versus those who do not, are 48 percent less likely to need eye surgery, and the total number of such surgeries is 37 percent less.
Illustration showing the retina as seen through a dilated pupil.

Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse.
Grantee News

Proteins critical to wound healing identified

Research at Washington University School of Medicine in St. Louis may have implications for treating diseases involving abnormal blood vessel growth, such as the impaired wound healing often seen in diabetes.
Grantee News

New Compound Treats Both Blindness and Diabetes in Animal Studies

In a new study, a chemical compound designed to precisely target part of a crucial cellular quality-control network provided significant protection, in rats and mice, against degenerative forms of blindness and diabetes.
Grantee News

IU School of Optometry study: New technique detects microscopic diabetes-related eye damage

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy
Grantee News

Parkinson's drugs could provide new avenue to treat diabetes-related vision problems

Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, Emory University researchers have discovered.
National Eye Institute logo.

This National Diabetes Month, remember to keep an eye on your eyes

If you are one of more than 25 million Americans with diabetes, you may already know the importance of watching your diet and keeping track of your blood sugar. But did you know it’s also important to have regular eye exams?
National Eye Institute logo.

ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
National Eye Institute logo.

Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema

Researchers have shown that ranibizumab eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.
National Eye Institute logo.

Older Treatment May Be More Effective in Preserving Sight for Some Patients with Diabetes

A promising new drug therapy used to treat abnormal swelling in the eye-a condition called diabetic macular edema-proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the NIH.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248